Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
C
|
CompuGroup Medical SE & Co KgaA
DUS:COP
|
DE |
|
T
|
TotalEnergies SE
DUS:TOTA
|
FR |
|
D
|
Deutsche Telekom AG
XMUN:DTE
|
DE |
|
D
|
Devon Energy Corp
BMV:DVN
|
US |
|
C
|
CENIT AG
XBER:CSH
|
DE |
|
Innocan Pharma Corp
OTC:INNPF
|
IL |
|
Komercni Banka as
PSE:KOMB
|
CZ |
|
ABC Arbitrage SA
OTC:ABCCF
|
FR |
|
H
|
Heritage Distilling Holding Company Inc
NASDAQ:IPST
|
US |
|
F
|
freenet AG
XHAM:FNTN
|
DE |
|
Liberty Global PLC
NASDAQ:LBTYA
|
UK |
|
W
|
Wells Fargo & Co
SWB:NWT
|
US |
|
E
|
Elisa Oyj
DUS:EIA
|
FI |
|
C
|
Carlsberg A/S
DUS:CBGB
|
DK |
|
M
|
Modine Manufacturing Co
XBER:MMF
|
US |
|
Pharol SGPS SA
F:PTCA
|
PT |
|
F
|
Freeport-McMoRan Inc
XETRA:FPMB
|
US |
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
Schibsted ASA
OSE:SCHB
|
NO |
Bankruptcy Probability
Recursion Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Recursion Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
1.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
382.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Recursion Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Recursion Pharmaceuticals Inc has total debt of 7.2m USD. This includes both short-term (0 USD) and long-term (7.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
